Since galectin-1 was practically always expressed by tumor infiltrating immune cells and galectin-3 among non-tumor cells by CD163+ macrophages, the galectin-1/3 double positive cells are expected to be tumor epithelium infiltrating CD163+ macrophages. The gene discussed is CD163; the disease is neoplasm.